1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with samarium in 3 studies
| Studies (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Trials (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)) | Studies (samarium) | Trials (samarium) | Recent Studies (post-2010) (samarium) |
|---|---|---|---|---|---|
| 25 | 4 | 8 | 979 | 42 | 325 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Crump, DK; Erwin, WD; Frank, RK; Simón, J; Ueno, NT; Wendt, RE | 1 |
| Arani, SS; Maraghe, MG; Mehrabi, M; Salek, N; Samani, AB; Vosoghi, S | 1 |
| Frank, RK; Ketring, AR; Simón, J; Wendt, RE | 1 |
3 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and samarium
| Article | Year |
|---|---|
A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.
Topics: Adult; Animals; Bone and Bones; Humans; Male; Organophosphorus Compounds; Radioisotopes; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Samarium | 2012 |
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.
Topics: Ablation Techniques; Animals; Bone Marrow; Femur; Lutetium; Mice; Models, Biological; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats, Wistar; Samarium; Tissue Distribution; Yttrium Radioisotopes | 2018 |
Dosimetric implications of the potential radionuclidic impurities in
Topics: Organophosphorus Compounds; Radioisotopes; Samarium | 2022 |